USANA Health Sciences (NYSE:USNA) Reaches New 12-Month Low – Here’s What Happened

Shares of USANA Health Sciences, Inc. (NYSE:USNA) reached a new 52-week low on Friday . The company traded as low as $34.08 and last traded at $34.08, with a volume of 22108 shares trading hands. The stock had previously closed at $34.71.

Wall Street Analyst Weigh In

A number of research firms have commented on USNA. StockNews.com raised USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research note on Thursday. DA Davidson cut their price target on USANA Health Sciences from $38.00 to $35.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 23rd.

USANA Health Sciences Price Performance

The business has a 50 day moving average of $37.98 and a 200 day moving average of $40.51. The firm has a market capitalization of $645.56 million, a price-to-earnings ratio of 11.97, a PEG ratio of 1.25 and a beta of 0.89.

USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.49 by $0.07. The company had revenue of $200.22 million during the quarter, compared to analyst estimates of $208.45 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. During the same period in the previous year, the company earned $0.59 EPS. As a group, equities analysts predict that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Insiders Place Their Bets

In other USANA Health Sciences news, Director Gilbert A. Fuller sold 675 shares of USANA Health Sciences stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $37.71, for a total value of $25,454.25. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 0.33% of the company’s stock.

Institutional Investors Weigh In On USANA Health Sciences

Several institutional investors have recently added to or reduced their stakes in USNA. Safe Harbor Fiduciary LLC bought a new stake in shares of USANA Health Sciences in the third quarter valued at about $30,000. KBC Group NV lifted its stake in USANA Health Sciences by 96.6% in the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock valued at $40,000 after acquiring an additional 519 shares in the last quarter. Centiva Capital LP acquired a new position in USANA Health Sciences during the 3rd quarter worth approximately $213,000. BOKF NA grew its stake in shares of USANA Health Sciences by 99.4% during the 2nd quarter. BOKF NA now owns 5,526 shares of the company’s stock worth $250,000 after acquiring an additional 2,755 shares in the last quarter. Finally, Quest Partners LLC acquired a new stake in shares of USANA Health Sciences in the third quarter valued at approximately $250,000. 54.25% of the stock is owned by institutional investors.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.